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Background
50% of mice with a classical deletion of the cGK Iá and Iβ
gene (cGKI-/-) die at 6 weeks [1] whereas 50% of cGK Iα
and Iβ rescue mice (RM) survive until one year [2]. Here,
we investigated the reason(s) for the premature death of
the different gene-targeted cGKI animals.
Results
cGKI-/- and the RM have a severe anemia and splenomeg-
alie which is associated with a strongly reduced iron con-
tent and expression of the ferritin light chain in the spleen.
Furthermore, the mRNA levels of transferrin receptor
(TfRc) and divalent metal ion transporter (DMT1) are
increased in the spleen. Oral or i.m. administration of
iron restores partially the iron levels in the spleen of gene-
targeted cGKI mice, but affects the anemia only moder-
ately. Examination of the intestinal tract showed a mas-
sive ulceration in the duodenum that caused intestinal
bleeding in cGKI-/- and at the later age in the RM as well.
The cGKI protein was expressed in smooth muscle cells of
all intestinal sections including the duodenum of RM.
However, H+  induced duodenal HCO3
-  secretion was
severely reduced in the cGKI-/- and RM. HCO3
- secretion
was measured as described in [3]. Interestingly, the duo-
denal HCO3
- secretion was not affected by targeted dele-
tion of the cGKI gene in the secretory epithel or in Cajal
cells. In line with this result, we did not detect the cGKI
protein by extensive immuno-cytochemical analysis in
the secretory epithel or Cajal cells.
Conclusion
These results confirm previous observations that cGKI
confers antiapoptotic/prosurvival function to erythrocytes
[4]. In addition, we propose that cGKI-/- and RM die
because of the massive intestinal bleedings caused by an
ulceration of the duodenum. We conclude that the cGMP/
cGKI pathway it is essential for H+ induced secretion of
HCO3
- thereby protecting the small intestine from gastric
acid injury.
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